Your browser doesn't support javascript.
loading
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.
Sesen, Julie; Cammas, Anne; Scotland, Sarah J; Elefterion, Bertand; Lemarié, Anthony; Millevoi, Stefania; Mathew, Lijoy K; Seva, Cathy; Toulas, Christine; Moyal, Elizabeth Cohen-Jonathan; Skuli, Nicolas.
Affiliation
  • Sesen J; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. julie.sesen@hotmail.fr.
  • Cammas A; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. anne.cammas@inserm.fr.
  • Scotland SJ; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. sarah.scotland1@gmail.com.
  • Elefterion B; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. elefterion.bertrand@live.fr.
  • Lemarié A; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. lemarie.anthony@claudiusregaud.fr.
  • Millevoi S; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. stefania.millevoi@inserm.fr.
  • Mathew LK; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA. mathewl@mail.med.upenn.edu.
  • Seva C; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. cathy.seva@inserm.fr.
  • Toulas C; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. toulas.christine@claudiusregaud.fr.
  • Moyal EC; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. moyal.elizabeth@claudiusregaud.fr.
  • Skuli N; INSERM U1037, Centre de Recherche en Cancérologie de Toulouse, 20-24 Rue du Pont St Pierre, 31052 Toulouse, Cedex, France. nicolas.skuli@inserm.fr.
Int J Mol Sci ; 15(2): 2172-90, 2014 Jan 29.
Article in En | MEDLINE | ID: mdl-24481065
ABSTRACT
Glioblastomas (GBM) are very aggressive and malignant brain tumors, with frequent relapses despite an appropriate treatment combining surgery, chemotherapy and radiotherapy. In GBM, hypoxia is a characteristic feature and activation of Hypoxia Inducible Factors (HIF-1α and HIF-2α) has been associated with resistance to anti-cancer therapeutics. Int6, also named eIF3e, is the "e" subunit of the translation initiation factor eIF3, and was identified as novel regulator of HIF-2α. Eukaryotic initiation factors (eIFs) are key factors regulating total protein synthesis, which controls cell growth, size and proliferation. The functional significance of Int6 and the effect of Int6/EIF3E gene silencing on human brain GBM has not yet been described and its role on the HIFs is unknown in glioma cells. In the present study, we show that Int6/eIF3e suppression affects cell proliferation, cell cycle and apoptosis of various GBM cells. We highlight that Int6 inhibition induces a diminution of proliferation through cell cycle arrest and increased apoptosis. Surprisingly, these phenotypes are independent of global cell translation inhibition and are accompanied by decreased HIF expression when Int6 is silenced. In conclusion, we demonstrate here that Int6/eIF3e is essential for proliferation and survival of GBM cells, presumably through modulation of the HIFs.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Eukaryotic Initiation Factor-3 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Eukaryotic Initiation Factor-3 Type of study: Prognostic_studies Limits: Humans Language: En Year: 2014 Type: Article